drugset / Trial / NCT02734849
Study to Evaluate Multiple Doses in Patients With Nasal Polyposis
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a phase 2 study to evaluate multiple doses of AK001 across 2 active doses. Pharmacodynamic activity will also be evaluated.
Timeline
- Start
- 2016-04
- Primary completion
- 2018-01
- Completion
- 2018-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AK001 | Monoclonal antibody | 25 mg | — |
| Subject | AK001 | Monoclonal antibody | 250 mg | — |